Market Tracker

10/23 3:43am ET

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

106.17
Data as of Oct 22
 -1.99 / -1.84%
Today’s Change
58.06
Today|||52-Week Range
116.88
+42.89%
Year-to-Date

Today’s Trading

Previous close108.16
Today’s open109.36
Day’s range106.00 - 111.00
Volume1,539,994
Average volume (3 months)1,663,484
Market cap$25.8B
Dividend yield--
Data as of 3:59pm ET, 10/22/2014

Growth & Valuation

Earnings growth (last year)-296.00%
Earnings growth (this year)-43.20%
Earnings growth (next 5 years)+159.50%
Revenue growth (last year)-20.63%
P/E ratioNM
Price/Sales13.79
Price/Book18.64

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC+0.10+0.07%
MYLMylan Inc-1.69-3.24%
ZTSZoetis Inc-0.20-0.55%
ALXNAlexion Pharmaceutic...-1.20-0.69%
Data as of 4:03pm ET, 10/22/2014

Financials

Next reporting dateOctober 27, 2014
EPS forecast (this quarter)-$0.63
Annual revenue (last year)$1.2B
Annual profit (last year)-$445.0M
Net profit margin-36.72%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeff M. Leiden
Chief Financial Officer &
Executive Vice President
Ian F. Smith
Corporate headquarters
Cambridge, Massachusetts

Forecasts